Tillomed Laboratories Limited, the European arm of Emcure Pharmaceuticals Ltd., has entered into an Asset
Emcure Pharmaceuticals, a leading player in India’s pharmaceutical sector, has officially opened its advanced Formulation
Emcure Pharmaceuticals (BSE:544210, NSE: EMCURE) announced solid financial results for the quarter ending September 30,
Emcure Pharmaceuticals (BSE:544210, NSE: EMCURE) has announced its unaudited consolidated financial results for the quarter
Emcure Pharmaceuticals, backed by Bain Capital, will launch its Initial Public Offering (IPO) on July
© 2024 All Right Reserved Machine Maker
